Provided is a method of producing a cured tobacco material having an enhanced threonine content. The present invention provides a method of producing a cured tobacco material having an enhanced threonine content, wherein the cured tobacco material is produced from a modified tobacco plant which has been modified such that expression or activity of an endogenous threonine aldolase is reduced or from a part of the modified tobacco plant.

A smokeless tobacco product is provided comprising a quantity of smokeless tobacco and a container to hold said tobacco. The container comprises a first side and a second side, wherein the first side is non-permeable to substances in the smokeless tobacco that may sting or harm the mucosae or gum of a user, and the second side is permeable to said substances in the smokeless tobacco. This product overcomes issues with pain and stinging that are caused by smokeless tobacco products.

Cannabis plant material is gently ground, mixed with chilled water and then agitated. The trichomes, being made brittle by the lowered temperature of the water, fall off the plant material during agitation. The mixture is then filtered in multiple stages to obtain the trichomes in different size fractions, which are collected separately and then dried.

Cannabis plant material is gently ground, mixed with chilled water and then agitated. The trichomes, being made brittle by the lowered temperature of the water, fall off the plant material during agitation. The mixture is then filtered in multiple stages to obtain the trichomes in different size fractions, which are collected separately and then dried.

A meltable smokeless tobacco composition configured for insertion into the mouth of a user is provided. The smokeless tobacco composition includes a tobacco material and a lipid having a melting point of about 36 C. to about 45 C. An associated process is also provided. The process includes melting a lipid having a melting point of about 36 C. to about 45 C. to form a molten lipid composition, mixing a tobacco material with the molten lipid composition to form a molten smokeless tobacco composition, and cooling the molten smokeless tobacco composition to form a solidified smokeless tobacco composition.

A composition that includes vitamin A (e.g., retinol) and vitamin E (e.g., gamma-tocopherol), suitable for at least one of pulmonary administration, aerosolization, and intranasal administration. The composition can further include a pharmaceutically acceptable solid or liquid carrier. The composition can be in a unit dosage form or a metered dosage form and can be configured for pulmonary or intranasal administration. Also included are nutritional supplements, intranasal sprays, pulmonary sprays, pulmonary powders, cigarettes, and/or electronic cigarettes, each including the composition. Also included are methods of administering the composition to a human, e.g., within the oral cavity or within the respiratory system.

A composition that includes vitamin A (e.g., retinol) and vitamin E (e.g., gamma-tocopherol), suitable for at least one of pulmonary administration, aerosolization, and intranasal administration. The composition can further include a pharmaceutically acceptable solid or liquid carrier. The composition can be in a unit dosage form or a metered dosage form and can be configured for pulmonary or intranasal administration. Also included are nutritional supplements, intranasal sprays, pulmonary sprays, pulmonary powders, cigarettes, and/or electronic cigarettes, each including the composition. Also included are methods of administering the composition to a human, e.g., within the oral cavity or within the respiratory system.

Cannabis plant material is gently ground, mixed with chilled water and then agitated. The trichomes, being made brittle by the lowered temperature of the water, fall off the plant material during agitation. The mixture is then filtered in multiple stages to obtain the trichomes in different size fractions, which are collected separately and then dried.

The present invention provides a cured hybrid tobacco plant or a part thereof made between a parent flue-cured tobacco plant and a parent non-flue-cured tobacco plant; which cured hybrid tobacco plant or a part thereof comprises one or more flavour compounds which are a breakdown product of cis-abienol at a concentration which is about equal to or greater than the concentration in the cured parent non-flue-cured tobacco plant.

A container containing a powder system including a first plurality of particles having a particle size of about 10 micrometers or less, and a second plurality of particles having a particle size of about 20 micrometers or greater, and a single aperture extending through the container. A system including an inhaler article and the container is disclosed also.